Lipegfilgrastim may cause hyperleukocytosis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552221082645
Abstract: Introduction Granulocyte colony-stimulating factors (G-CSF) are utilized both in the treatment and prophylaxis of chemotherapy-induced neutropenia. Lipegfilgrastim is a long-acting G-CSF. Albeit it provides ease of administration compared to short-acting GCSFs, some lipegfilgrastim-related adverse events… read more here.
Keywords: cause hyperleukocytosis; lipegfilgrastim; may occur; may cause ... See more keywords